Zynex Total Assets 2006-2018 | ZYXI

Zynex total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
Zynex Annual Total Assets
(Millions of US $)
2018 $16
2017 $9
2016 $4
2015 $4
2014 $7
2013 $17
2012 $26
2011 $22
2010 $16
2009 $12
2008 $11
2007 $7
2006 $3
2005 $1
Zynex Quarterly Total Assets
(Millions of US $)
Q4 2018 $16
Q3 2018 $13
Q2 2018 $11
Q1 2018 $9
Q4 2017 $9
Q3 2017 $6
Q2 2017 $4
Q1 2017 $4
Q4 2016 $4
Q3 2016 $5
Q2 2016 $4
Q1 2016 $4
Q4 2015 $4
Q3 2015 $5
Q2 2015 $5
Q1 2015 $6
Q4 2014 $7
Q3 2014 $10
Q2 2014 $11
Q1 2014 $16
Q4 2013 $17
Q3 2013 $23
Q2 2013 $24
Q1 2013 $25
Q4 2012 $26
Q3 2012 $26
Q2 2012 $25
Q1 2012 $24
Q4 2011 $22
Q3 2011 $21
Q2 2011 $19
Q1 2011 $17
Q4 2010 $16
Q3 2010 $15
Q2 2010 $13
Q1 2010 $14
Q4 2009 $12
Q3 2009 $12
Q2 2009 $12
Q1 2009 $12
Q4 2008 $11
Q3 2008 $14
Q2 2008 $11
Q1 2008 $9
Q4 2007 $7
Q3 2007 $5
Q2 2007 $4
Q1 2007 $3
Q4 2006 $3
Q3 2006 $2
Q2 2006 $2
Q1 2006 $2
Q4 2005 $1
Q3 2005 $1
Q2 2005 $1
Q1 2005 $1
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.174B $0.032B
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $137.198B 26.75
Medtronic (MDT) Ireland $116.492B 17.03
Stryker (SYK) United States $69.834B 24.92
Boston Scientific (BSX) United States $51.351B 24.62
Baxter (BAX) United States $38.973B 24.52
Zimmer Biomet Holdings (ZBH) United States $25.515B 16.33
Smith & Nephew SNATS (SNN) United Kingdom $16.913B 0.00
Canopy Growth (CGC) Canada $16.587B 0.00
ResMed (RMD) United States $14.652B 27.78
Aurora Cannabis (ACB) Canada $9.189B 64.79
Bio-Rad Laboratories (BIO) United States $8.907B 51.09
Perrigo (PRGO) Ireland $6.811B 11.04
Hill-Rom Holdings (HRC) United States $6.475B 20.03
Insulet (PODD) United States $4.964B 1664.00
GW Pharmaceuticals (GWPH) United Kingdom $4.900B 0.00
ICU Medical (ICUI) United States $4.648B 28.79
Haemonetics (HAE) United States $4.345B 38.54
Hutchison China MediTech (HCM) China $3.899B 0.00
Agios Pharmaceuticals (AGIO) United States $3.354B 0.00
NuVasive (NUVA) United States $3.069B 26.66
Neogen (NEOG) United States $3.016B 49.04
Quidel (QDEL) United States $2.490B 22.28
National Vision Holdings (EYE) United States $2.281B 44.86
Aphria (APHA) $1.919B 0.00
HEXO (HEXO) $1.510B 0.00
Phibro Animal Health (PAHC) United States $1.352B 19.44
Cardiovascular Systems (CSII) United States $1.222B 877.50
VAREX IMAGING (VREX) United States $1.214B 23.77
AtriCure (ATRC) United States $1.089B 0.00
Lantheus Holdings (LNTH) United States $0.960B 25.95
Omeros (OMER) United States $0.920B 0.00
PetIQ (PETQ) United States $0.871B 24.92
Cerus (CERS) United States $0.823B 0.00
MacroGenics (MGNX) United States $0.813B 0.00
NanoString Technologies (NSTG) United States $0.787B 0.00
Evolus (EOLS) United States $0.756B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.734B 24.99
TG Therapeutics (TGTX) United States $0.712B 0.00
OraSure Technologies (OSUR) United States $0.591B 25.76
LeMaitre Vascular (LMAT) United States $0.569B 27.03
Surmodics (SRDX) United States $0.567B 82.39
Meridian Bioscience (VIVO) United States $0.550B 16.38
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.320B 0.00
Utah Medical Products (UTMD) United States $0.317B 21.92
Insys Therapeutics (INSY) United States $0.314B 0.00
BioLife Solutions (BLFS) United States $0.308B 127.08
Vapotherm (VAPO) United States $0.293B 0.00
Rockwell Medical (RMTI) United States $0.267B 0.00
Cytosorbents (CTSO) United States $0.229B 0.00
Owens & Minor (OMI) United States $0.216B 2.96
Bovie Medical (APYX) United States $0.161B 0.00
Fonar (FONR) United States $0.130B 6.96
Chimerix (CMRX) United States $0.129B 0.00
Chembio Diagnostics (CEMI) United States $0.125B 0.00
Surface Oncology (SURF) United States $0.112B 0.00
United-Guardian (UG) United States $0.089B 20.32
InfuSystems Holdings (INFU) United States $0.086B 0.00
Female Health (VERU) United States $0.085B 0.00
Neurotrope (NTRP) United States $0.076B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.79
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
GUARDION HEALTH (GHSI) United States $0.045B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.023B 0.00
Myomo (MYO) United States $0.020B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.006B 5.87